Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Factors Associated With the No-Reflow Phenomenon Following Percutaneous Intervention of Saphenous Vein Coronary Bypass Grafts



Hashemijazi M1 ; Hosseini SM2 ; Gholamrezaei A3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: ARYA Atherosclerosis Published:2017

Abstract

BACKGROUND: We investigated clinical and procedural factors associated with the no-reflow phenomenon following percutaneous coronary intervention (PCI) of the saphenous-vein grafts (SVG). METHODS: A cross-sectional study was done on patients who had undergone PCI of the SVG. Patients’ medical documents were reviewed for demographic, clinical, laboratory, and procedural data. Slow/no-reflow was defined based on the thrombolysis in myocardial infarction (TIMI) grade (0 to 2). Univariate and multiple logistic regression analyses were performed to investigate factors associated with slow/no-reflow and P < 0.050 was considered as significant. RESULTS: A total of 205 patients were studied (81% man, mean ± standard deviation of age was 66.8 ± 9.6 years). Slow/no-reflow was found in 38 (18.5%) patients. High diastolic blood pressure (P = 0.010), leukocytosis (P = 0.017), diffuse lesions (P = 0.007), degenerated SVG (P < 0.001), proximal lesions (P < 0.001), thrombosis (P = 0.013), and lower number of used stents during procedure (P = 0.032) were associated with slow/no-reflow in unadjusted analyses. Factors independently associated with slow/no-reflow were pre-procedural high diastolic blood pressure with odds ratio (OR) = 3.858 [95% confidence interval (95% CI), 1.157-12.860], degenerated SVG with OR = 5.901 (95% CI: 1.883-18.492), proximal lesions with OR = 5.070 (95% CI: 1.822-14.113), pre-intervention TIMI grade with OR = 0.618 (95% CI: 0.405-0.942), number of used stents for PCI with OR = 0.074 (95% CI: 0.011-0.481) for > 1 stent, and length of stents used for PCI with OR = 0.100 (95% CI: 0.019-0.529) for > 30 mm stents. CONCLUSION: This study on the clinical and procedural factors associated with the slow/no-reflow phenomenon following PCI of the SVG can be used in risk estimation of this serious complication and tailoring preventive strategies to at-risk patients. © 2017, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Clinical, Laboratory, and Procedural Predictors of Slow Flow/No Reflow Phenomenon After Emergency Percutaneous Coronary Interventions in St-Elevated Myocardial Infarction, Egyptian Heart Journal (2024)
2. Long-Term Outcome and Prognostic Value of Angiographic Slow/No-Reflow Phenomenon After Emergency Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction, Coronary Artery Disease (2024)
3. Comparison of No-Reflow Phenomenon After Percutaneous Coronary Intervention for Acute Myocardial Infarction Between Smokers and Nonsmokers, Journal of Research in Medical Sciences (2014)
4. The Assessment of No-Reflow Phenomenon Incidence in Early Versus Delayed Percutaneous Coronary Intervention Following a Primary Fibrinolysis, ARYA Atherosclerosis (2024)
5. Does Adjunctive Prophylactic Intracoronary Infusion of Low Dose Alteplase Prevent No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention?, ARYA Atherosclerosis (2023)
6. Comparison of the One-Year Outcome Between Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease, Iranian Heart Journal (2022)
7. Blood Group Types and Clinical, Procedural, and Adverse Outcomes in St-Elevated Myocardial Infarction Patients: A 3-Year Cohort in Iran, Journal of Research in Medical Sciences (2023)
8. Medical Therapy Versus Percutaneous Coronary Intervention or Coronary Artery Bypass Graft in Stable Coronary Artery Disease; a Systematic Review and Meta-Analysis of Randomized Clinical Trials, ARYA Atherosclerosis (2022)
Experts (# of related papers)
View all Related Experts
Masoumeh Sadeghi (17)
Alireza Khosravi (9)
Other Related Docs
9. The Pragmatic Role of Covid-19 on the Thrombus Grade of Patients With Contemporary St-Segment-Elevation Myocardial Infarction, Journal of Tehran University Heart Center (2022)
10. Angiotensin Converting Enzyme Insertion/Deletion Polymorphism and Occlusion of Vein Grafts in Long-Term Post-Cabg, Journal of Isfahan Medical School (2012)
11. Transulnar Versus Transradial Approach for Coronary Angiography and Angioplasty: Considering Their Complications, ARYA Atherosclerosis (2018)
12. The Effect of Intracoronary Versus Intralesional Injection of Eptifibatide on Myocardial Perfusion Outcomes During Primary Percutaneous Coronary Intervention in Acute St-Segment Elevation Myocardial Infarction; a Randomized Clinical Trial Study, ARYA Atherosclerosis (2019)
13. Assessment of Metabolic Risk Factors and Heart-Healthy Lifestyle in Atherosclerotic Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention After a 6-Month Follow-Up, Advanced Biomedical Research (2022)
14. Relationship Between Complete Revascularization and Survival After Post-Infarction Ventricular Septal Rupture, ARYA Atherosclerosis (2023)
15. Comparison of Survival Rate and Complications of Percutaneous Coronary Intervention, Coronary Artery Bypass Graft, and Medical Treatment in Patients With Left Main And/Or Three Vessel Diseases, ARYA Atherosclerosis (2020)
16. Reperfusion Therapies and In-Hospital Outcomes for St-Elevation Myocardial Infarction in Europe: The Acvc-Eapci Eorp Stemi Registry of the European Society of Cardiology, European Heart Journal (2021)
17. Qt Dispersion and Age; Independent Predictors of Restenosis After Percutaneous Coronary Intervention, Reviews on Recent Clinical Trials (2017)
18. Factors Affecting Outcome of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction, ARYA Atherosclerosis (2013)
19. Differences Between the Characteristics of Ihd Patients Undergoing Different Treatment Modalities Who Adhere to Cardiac Rehabilitation Programs, Iranian Heart Journal (2014)
20. The Comparison of Procedural and Clinical Outcomes of Thrombolytic-Facilitated and Primary Percutaneous Coronary Intervention in Patients With Acute St-Elevation Myocardial Infarction (Stemi): Findings From Prove/Acs Study, ARYA Atherosclerosis (2020)
21. The Correlation Between Early Complications of Percutaneous Coronary Intervention and High Sensitive C-Reactive Protein, ARYA Atherosclerosis (2013)
22. Analysis of Traditional Risk Factors on St-Segment Elevation Myocardial Infarction Characteristics; [بررسی عوامل خطر سنتی مرتبط با ویژگیهای بالینی بیماران انفارکتوس میوکارد با بالارونده قطعه St], Journal of Isfahan Medical School (2024)
23. The Role of Manual Thrombectomy in Cardiovascular Outcome Among Patients With Total Cutoff Vessel Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention, ARYA Atherosclerosis (2017)
24. Evaluating the Impact of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Lesions on the Mode of Treatment and Their Outcomes: An Iranian Experie, ARYA Atherosclerosis (2015)
25. Cardiovascular and Bleeding Events of Ticagrelor Monotherapy After Short-Term Dual Antiplatelet Therapy (Dapt) in Diabetics and Non-Diabetics Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis, ARYA Atherosclerosis (2023)
26. The Impact of Generic Form of Clopidogrel on Cardiovascular Events in Patients With Coronary Artery Stent: Results of the Opces Study, Journal of Research in Medical Sciences (2011)
27. Risk Factor Profile and Outcomes of Premature Acute Coronary Syndrome After Percutaneous Coronary Intervention: A 1-Year Prospective Design, Clinical Cardiology (2024)
28. Which Majot Atherosclerosis’ Risk Factors Represents the Extent of Coronary Artery Disease?, Journal of Isfahan Medical School (2007)
29. Immediate Results and Six-Month Outcomes After Percutaneous Coronary Intervention in a Referral Heart Center in Isfahan, Iran, ARYA Atherosclerosis (2011)
30. Evaluation of Coronary Angioplasty Results in Patients Referring to Isfahan Cardiac Centers, Iran, and Comparing With Clinical Guidelines, Journal of Isfahan Medical School (2017)
31. Rationale, Design, and Preliminary Results of the Iran-Premature Coronary Artery Disease Study (I-Pad): A Multi-Center Case-Control Study of Different Iranian Ethnicities, ARYA Atherosclerosis (2020)
32. Can Cardiac Rehabilitation Programs Improve Functional Capacity and Left Ventricular Diastolic Function in Patients With Mechanical Reperfusion After St Elevation Myocardial Infarction?: A Double-Blind Clinical Trial, ARYA Atherosclerosis (2012)
33. Effect of Streptokinase on Short-Term Outcomes in the Acute Myocardial Infarction With St-Segment Elevation, Journal of Reports in Pharmaceutical Sciences (2014)
34. Atherosclerosis Risk Factors in Children and Adolescents With or Without Family History of Premature Coronary Artery Disease, Medical Science Monitor (2002)
35. Background and Design of a 5-Year St Elevation Myocardial Infarction Cohort in Isfahan, Iran: Semi-Ci Study, ARYA Atherosclerosis (2022)
36. Comparison of Health-Related Quality of Life After Percutaneous Coronary Intervention and Coronary Artery Bypass Surgery, ARYA Atherosclerosis (2016)
37. In-Hospital and 1-Year Outcomes of Patients Without Modifiable Risk Factors Presenting With Acute Coronary Syndrome Undergoing Pci: A Sex-Stratified Analysis, Frontiers in Cardiovascular Medicine (2023)
38. Reperfusion Therapy for St-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: The European Society of Cardiology Eurobservational Programme Acute Cardiovascular Care-European Association of Pci St-Elevation Myocardial Infarction Registry, European Heart Journal: Acute Cardiovascular Care (2022)